Astrana Health, Inc. Reports Third Quarter 2026 Results
PR Newswire•05/11/2026•16:05 ET
0
Key Highlights
- ➤Q3 revenue $1,023.6 million, up 7% year-over-year
- ➤Q3 net income attributable to Astrana $13.0 million, up 3,373%
- ➤Q3 adjusted EBITDA $77.2 million, up 13% year-over-year
- ➤2026 revenue guidance narrowed to $3.9 billion-$4.0 billion
- ➤2026 adjusted EBITDA guidance narrowed to $261 million-$274 million
Expert Statements
Brandon Sim, President and Chief Executive Officer of Astrana Health
“Our third quarter results demonstrate the growing impact of Astrana's physician-centric, AI-native healthcare operating platform and our team's continued focus on execution.”
Brandon Sim, President and Chief Executive Officer of Astrana Health
“We delivered record revenue, record adjusted EBITDA, and double-digit organic earnings growth while continuing to invest in the next phase of our growth.”
Brandon Sim, President and Chief Executive Officer of Astrana Health
“By combining proprietary technology, aligned physician partnerships, and integrated care delivery, we're building a scalable, repeatable model to improve patient outcomes and manage the total cost of care – a value proposition that extends across payer and reimbursement models and positions us to create sustainable long-term value for patients, physician partners, and shareholders.”
Astrana Health, Inc. Reports Third Quarter 2026 Results PR Newswire
Company to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m. ET
Get started
Create a free account to read the full story.